Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway.
galunisertib（LY2157299 一水合物）是一种转化生长因子-β信号通路的小分子抑制剂，目前正在进行临床开发
期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S86621
Herbertz Stephan, Sawyer J Scott, Stauber Anja J, Gueorguieva Ivelina, Driscoll Kyla E, Estrem Shawn T, Cleverly Ann L, Desaiah Durisala, Guba Susan C, Benhadji Karim A, Slapak Christopher A, Lahn Michael M
